Back to Search
Start Over
The Prevalence, Clinical Spectrum and the Long Term Outcome of ST-segment Elevation Myocardial Infarction in Young - A Prospective Observational Study.
- Source :
-
Cardiovascular Revascularization Medicine . May2019, Vol. 20 Issue 5, p387-391. 5p. - Publication Year :
- 2019
-
Abstract
- <bold>Introduction: </bold>Incidence of coronary artery disease at the younger age is rising. We studied the prevalence, clinical spectrum and long term outcome of ST-segment elevation myocardial infarction in young.<bold>Material and Methods: </bold>This is a prospective observational study, performed at a tertiary care center from January 2015 to June 2016. Of the total 977 consecutive patients with ST segment elevation myocardial infarction (STEMI), 130 patients aged ≤45 years were included. All patients were followed-up for at least 1-year from the index admission.<bold>Results: </bold>The overall prevalence of STEMI among younger patients was 12.8%. There was male dominance (96.8%). Smoking (37.6%) was observed to be the most common risk factor for young STEMI, followed by diabetes mellitus (16.8%) and hypertension (16%). Younger patients with acute MI had preponderance to anterior wall (68.8%), single-vessel disease (50%) and left anterior descending artery being the culprit lesion (67.3%). Near normal/normal coronary arteries were observed in 12.9% of cases. The most commonly used management strategy was mechanical revascularisation (43.2%), followed by thrombolysis (28.8%) and medical management (28%). The overall mortality and combined MACCE rates at 1 year were 3.2% and 18.4% respectively. Outcome was better in patients who received mechanical revascularization/thrombolysis than those who received medical management only, with a lower MACCE rates (hazard ratio: 0.36; 95% CI: 0.16-0.8, p = 0.01.<bold>Conclusion: </bold>The young MI patients are unique in having male dominance, better outcome, more of single-vessel disease with significant number of normal coronaries, better response to mechanical as well as pharmacological revascularization. [ABSTRACT FROM AUTHOR]
- Subjects :
- *MYOCARDIAL infarction
*LONGITUDINAL method
*CORONARY disease
*SCIENTIFIC observation
*CORONARY arteries
*MYOCARDIAL infarction treatment
*HYPERTENSION epidemiology
*RESEARCH
*TIME
*RESEARCH methodology
*DIABETES
*THROMBOLYTIC therapy
*EVALUATION research
*MEDICAL cooperation
*RISK assessment
*CARDIOVASCULAR agents
*TREATMENT effectiveness
*COMPARATIVE studies
*DISEASE prevalence
*AGE factors in disease
*MYOCARDIAL revascularization
*SMOKING
*DEMOGRAPHY
MYOCARDIAL infarction-related mortality
Subjects
Details
- Language :
- English
- ISSN :
- 15538389
- Volume :
- 20
- Issue :
- 5
- Database :
- Academic Search Index
- Journal :
- Cardiovascular Revascularization Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 136342296
- Full Text :
- https://doi.org/10.1016/j.carrev.2018.07.020